AdvertisementSupported byBy Chad BrayLONDON — Refresco Gerber, one of Europe’s largest bottlers of soft drinks and fruit juices, said on Tuesday that the expected price range for its initial public offering could value the company at up to 1.29 billion euros, or about $1.36 billion.Refresco Gerber, based in Rotterdam, the Netherlands, expects to price its stock at €13 to €16 a share, raising as much as €594 million. That would value the company at €1.29 billion at the top end of the range.If an overallotment of shares is fully exercised, the company would expect to sell shares representing up to 54.2 percent of its capital. The company announced its plans for an I.P.O. this month.“The anticipated listing is a milestone development for our company; an important step that will enable us to continue our ambitious plans to provide a high-quality bottling platform that meets our customer needs in each of the countries they operate,” Hans Roelofs, the Refresco Gerber chief executive, said in a news release.Refresco Gerber expects its shares to begin trading on Euronext in Amsterdam on March 27.The I.P.O. will consist of new shares issued by Refresco Gerber and a sale of about 30.9 million shares held by Refresco Gerber’s private equity owners, which include 3i Group.The company expects to receive gross proceeds of €100 million from the offering, which will be used to repay debt and give it additional financial flexibility.Institutional investors and retail investors in the Netherlands and certain institutional investors in other jurisdictions will be able to buy shares in the offering.Founded in 1999, Refresco Gerber has significantly expanded its business through a series of acquisitions, the most recent being Gerber Emig in 2013. It employs about 4,100 people in nine countries.In 2014, the company reported adjusted earnings before interest, taxes and amortization of €208.2 million, compared with €139.7 million in 2013.JPMorgan Chase and Credit Suisse are serving as joint global coordinators on the offering.Advertisement